• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 与胰腺癌:从生物学到治疗潜能。

MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.

机构信息

Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.

Department of Biotechnology, Kumaun University, Nainital, Uttarakhand 263001, India.

出版信息

Genes (Basel). 2019 Sep 25;10(10):752. doi: 10.3390/genes10100752.

DOI:10.3390/genes10100752
PMID:31557962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6827136/
Abstract

Pancreatic cancer is one of the most aggressive malignancies, accounting for more than 45,750 deaths annually in the U.S. alone. The aggressive nature and late diagnosis of pancreatic cancer, coupled with the limitations of existing chemotherapy, present the pressing need for the development of novel therapeutic strategies. Recent reports have demonstrated a critical role of microRNAs (miRNAs) in the initiation, progression, and metastasis of cancer. Furthermore, aberrant expressions of miRNAs have often been associated with the cause and consequence of pancreatic cancer, emphasizing the possible use of miRNAs in the effective management of pancreatic cancer patients. In this review, we provide a brief overview of miRNA biogenesis and its role in fundamental cellular process and miRNA studies in pancreatic cancer patients and animal models. Subsequent sections narrate the role of miRNA in, (i) cell cycle and proliferation; (ii) apoptosis; (iii) invasions and metastasis; and (iv) various cellular signaling pathways. We also describe the role of miRNA's in pancreatic cancer; (i) diagnosis; (ii) prognosis and (iii) therapeutic intervention. Conclusion section describes the gist of review with future directions.

摘要

胰腺癌是最具侵袭性的恶性肿瘤之一,仅在美国每年就有超过 45750 人因此死亡。胰腺癌具有侵袭性和晚期诊断的特点,再加上现有化疗的局限性,迫切需要开发新的治疗策略。最近的报告表明,微小 RNA(miRNA)在癌症的发生、发展和转移中起着关键作用。此外,miRNA 的异常表达通常与胰腺癌的病因和后果有关,这强调了 miRNA 在有效管理胰腺癌患者方面的可能用途。在这篇综述中,我们简要概述了 miRNA 的生物发生及其在基本细胞过程中的作用,以及 miRNA 在胰腺癌患者和动物模型中的研究。随后的部分叙述了 miRNA 在(i)细胞周期和增殖;(ii)细胞凋亡;(iii)侵袭和转移;和(iv)各种细胞信号通路中的作用。我们还描述了 miRNA 在胰腺癌中的作用;(i)诊断;(ii)预后和(iii)治疗干预。结论部分描述了综述的要点和未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/9467adff184f/genes-10-00752-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/bfa19b9634e1/genes-10-00752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/8bf5cae756f1/genes-10-00752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/fe51a065c632/genes-10-00752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/9467adff184f/genes-10-00752-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/bfa19b9634e1/genes-10-00752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/8bf5cae756f1/genes-10-00752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/fe51a065c632/genes-10-00752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f5/6827136/9467adff184f/genes-10-00752-g004.jpg

相似文献

1
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.微小 RNA 与胰腺癌:从生物学到治疗潜能。
Genes (Basel). 2019 Sep 25;10(10):752. doi: 10.3390/genes10100752.
2
MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.微小 RNA 作为生物标志物及其在胰腺癌治疗中的应用前景。
Mol Cell Biochem. 2021 Dec;476(12):4191-4203. doi: 10.1007/s11010-021-04233-y. Epub 2021 Jul 29.
3
Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.胰腺癌的管理:microRNA基因治疗的特别关注点
Int J Mol Sci. 2016 May 13;17(5):718. doi: 10.3390/ijms17050718.
4
[Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].微小RNA在胰腺癌诊断、治疗及预后评估中的应用
Zhonghua Zhong Liu Za Zhi. 2020 Nov 23;42(11):903-906. doi: 10.3760/cma.j.cn112152-20190313-00152.
5
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.微小RNA在胰腺癌发病机制、诊断及治疗中的临床意义
Adv Drug Deliv Rev. 2015 Jan;81:16-33. doi: 10.1016/j.addr.2014.10.020. Epub 2014 Oct 23.
6
Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.深入了解微小RNA在胰腺癌发病机制中的作用:诊断、预后及治疗潜力
Adv Exp Med Biol. 2015;889:71-87. doi: 10.1007/978-3-319-23730-5_5.
7
Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.胰腺癌中异常的 microRNAs 表达模式及其临床转化。
Cancer Biother Radiopharm. 2013 Jun;28(5):361-9. doi: 10.1089/cbr.2012.1389. Epub 2013 Apr 27.
8
Developments in miRNA gene signaling pathways in pancreatic cancer.胰腺癌中miRNA基因信号通路的进展
Future Oncol. 2016 May;12(9):1135-50. doi: 10.2217/fon-2015-0050. Epub 2016 Mar 17.
9
MicroRNAs as potential therapeutic targets for pancreatic cancer.微小 RNA 作为胰腺癌潜在的治疗靶点。
Chin Med J (Engl). 2022 Jan 5;135(1):4-10. doi: 10.1097/CM9.0000000000001826.
10
MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.微小RNA作为结肠癌和胰腺癌的生物标志物及潜在治疗靶点
Tumour Biol. 2016 Jan;37(1):97-104. doi: 10.1007/s13277-015-4346-6. Epub 2015 Nov 4.

引用本文的文献

1
Targeting miR-32-5p suppresses c-MYC-driven proliferation and induces apoptosis in MCF-7 breast cancer cells.靶向miR-32-5p可抑制c-MYC驱动的MCF-7乳腺癌细胞增殖并诱导其凋亡。
Med Oncol. 2025 Jul 25;42(9):377. doi: 10.1007/s12032-025-02935-7.
2
Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications.胰腺癌中的新兴肿瘤生物标志物及其临床意义
Curr Issues Mol Biol. 2025 May 10;47(5):347. doi: 10.3390/cimb47050347.
3
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.

本文引用的文献

1
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
2
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.胰腺癌代谢在肿瘤进展和治疗抵抗中的可塑性。
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):67-75. doi: 10.1016/j.bbcan.2018.04.011. Epub 2018 Apr 24.
3
Metazoan MicroRNAs.后生动物 MicroRNAs。
miR-216a-5p和miR-125a-5p对胰腺癌干细胞的功能表征
Int J Mol Sci. 2025 Mar 21;26(7):2830. doi: 10.3390/ijms26072830.
4
Diagnostic and Prognostic Accuracy of MiRNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis.微小RNA在胰腺癌中的诊断和预后准确性:一项系统评价和荟萃分析
J Cell Mol Med. 2025 Jan;29(2):e70337. doi: 10.1111/jcmm.70337.
5
Significant association of miRNA 34a with BRCA1 expression in pancreatic ductal adenocarcinoma: an insight on miRNA regulatory pathways in the Pakistani population.miRNA 34a与胰腺导管腺癌中BRCA1表达的显著关联:对巴基斯坦人群中miRNA调控途径的见解
BMC Cancer. 2024 Dec 18;24(1):1543. doi: 10.1186/s12885-024-13259-6.
6
Analysis of Candidate miRNAs' Expression in Pancreatic Cancer.胰腺癌候选 miRNA 表达分析。
Cancer Med. 2024 Nov;13(21):e70400. doi: 10.1002/cam4.70400.
7
Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models.揭示胰腺导管腺癌患者和癌细胞模型中的 microRNA 图谱。
BMC Cancer. 2024 Oct 24;24(1):1308. doi: 10.1186/s12885-024-13007-w.
8
Correlation analysis between the expression of serum microRNA-665 and the degree of coronary artery stenosis and major adverse cardiovascular events in patients with acute myocardial infarction.血清 microRNA-665 表达与急性心肌梗死患者冠状动脉狭窄程度及主要不良心血管事件的相关性分析。
J Cardiothorac Surg. 2024 Sep 23;19(1):543. doi: 10.1186/s13019-024-02998-z.
9
MiRNAs: a new target for Chinese medicine to repair the intestinal barrier in the treatment of ulcerative colitis.微小RNA:中药修复溃疡性结肠炎肠屏障治疗的新靶点
Front Pharmacol. 2024 Aug 9;15:1446554. doi: 10.3389/fphar.2024.1446554. eCollection 2024.
10
The role of microRNAs in the gastric cancer tumor microenvironment.微小 RNA 在胃癌肿瘤微环境中的作用。
Mol Cancer. 2024 Aug 20;23(1):170. doi: 10.1186/s12943-024-02084-x.
Cell. 2018 Mar 22;173(1):20-51. doi: 10.1016/j.cell.2018.03.006.
4
A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.miRNAs 作为胃肠胰神经内分泌肿瘤生物标志物作用的综合评估。
Neuroendocrinology. 2018;107(1):73-90. doi: 10.1159/000487326. Epub 2018 Mar 22.
5
High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5.微小RNA-4295的高表达通过下调磷脂酰肌醇蛋白聚糖-5促进胰腺导管腺癌的细胞增殖和侵袭。
Biochem Biophys Res Commun. 2018 Feb 26;497(1):73-79. doi: 10.1016/j.bbrc.2018.02.023. Epub 2018 Feb 3.
6
Personalized RNA Medicine for Pancreatic Cancer.胰腺癌的个体化 RNA 药物治疗。
Clin Cancer Res. 2018 Apr 1;24(7):1734-1747. doi: 10.1158/1078-0432.CCR-17-2733. Epub 2018 Jan 12.
7
Microprocessor Recruitment to Elongating RNA Polymerase II Is Required for Differential Expression of MicroRNAs.微处理器招募到延伸的 RNA 聚合酶 II 是差异表达 microRNAs 所必需的。
Cell Rep. 2017 Sep 26;20(13):3123-3134. doi: 10.1016/j.celrep.2017.09.010.
8
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.组织微小RNA谱作为可切除性胰腺导管腺癌和壶腹周围癌患者的诊断和预后生物标志物
Biomark Res. 2017 Feb 21;5:8. doi: 10.1186/s40364-017-0087-6. eCollection 2017.
9
miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway.miR-34a 通过 Snail1 介导的上皮-间充质转化和 Notch 信号通路抑制胰腺癌进展。
Sci Rep. 2017 Feb 1;7:38232. doi: 10.1038/srep38232.
10
MicroRNA in pancreatic cancer.胰腺癌中的微小RNA
J Hum Genet. 2017 Jan;62(1):33-40. doi: 10.1038/jhg.2016.59. Epub 2016 Jun 2.